Clinical Trial Update: A Randomized Double Blind, Placebo Controlled Balanced 4-Way Crossover Study To Assess The Efficacy Of Single Oral Doses [Phase 2]

View source ↗

Summary

Pfizer conducted a randomized, double-blind, placebo-controlled Phase 2 4-way crossover trial to assess the efficacy of a single oral dose for erectile dysfunct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Snippet

Sponsor: Pfizer | Conditions: Impotence | Phase 2 | Status: COMPLETED